A pneumococcal conjugate vaccine and acute otitis media [2]

New England Journal of Medicine

Volumn 344, Issue 22, 2001, Pages 1719-1720

  Lavin, Arthur ^a   Ofran, Yishay ^b   Ofran, Ariella ^c   Sauder, Kurtis L ^d   Damoiseaux, Roger A M J ^e   Cantekin, Erdem I ^f   Kilpi, Terhi ^g   Eskola, Juhani ^g   Mäkelä, P Helena ^g  

^a Pediatric Partners of Cleveland   (United States)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^c MACCABI HEALTHCARE SERVICES   (Israel)

^d Blue Ridge Pediatrics   (United States)

^e School of Medicine ^*  (Netherlands)

^f UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^g NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; PNEUMOCOCCUS VACCINE; ANTIINFECTIVE AGENT; HEPTAVALENT PNEUMOCOCCAL CONJUGATE VACCINE; MENINGOCOCCUS VACCINE; VACCINE;

ACUTE DISEASE; ANTIBIOTIC THERAPY; CLINICAL TRIAL; DRUG EFFICACY; DRUG INDICATION; HUMAN; LETTER; OTITIS MEDIA; PRIORITY JOURNAL; STREPTOCOCCUS INFECTION; VACCINATION; INFANT; NOTE; TREATMENT OUTCOME; CLASSIFICATION; MICROBIOLOGY; RECURRENT DISEASE; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; RISK; UNITED STATES; INCIDENCE;

ACUTE DISEASE; ANTI-BACTERIAL AGENTS; HUMANS; INFANT; MENINGOCOCCAL VACCINES; OTITIS MEDIA; PNEUMOCOCCAL VACCINES; TREATMENT OUTCOME; VACCINES, CONJUGATE; RECURRENCE; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; RISK; UNITED STATES; INCIDENCE;

EID: 0035978829     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200105313442213     Document Type: Letter

References (0)